» Articles » PMID: 29304237

Performance of the Net Reclassification Improvement for Nonnested Models and a Novel Percentile-Based Alternative

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2018 Jan 6
PMID 29304237
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The net reclassification improvement (NRI) is a widely used metric used to assess the relative ability of 2 risk models to distinguish between low- and high-risk individuals. However, the validity and usefulness of the NRI have been questioned. Criticism of the NRI focuses on its use comparing nested risk models, whereas in practice it is often used to compare nonnested risk models derived from distinct data sources. In this study, we evaluated the performance of the NRI in a nonnested context by using it to compare competing cardiovascular risk-prediction models. We explored the NRI's sensitivity to variations in risk categories and to the calibration of the compared models. We found that the NRI was very sensitive to changes in the definition of risk categories, especially when at least 1 model was miscalibrated. To address these shortcomings, we describe a novel alternative to the usual NRI that uses percentiles of risk instead of cutoffs based on absolute risk. This percentile-based NRI demonstrates the relative ability of 2 models to rank patient risk. It displays more stable behavior, and we recommend its use when there are no established risk categories or when models are miscalibrated.

Citing Articles

Comparative studies of 2168 plasma proteins measured by two affinity-based platforms in 4000 Chinese adults.

Wang B, Pozarickij A, Mazidi M, Wright N, Yao P, Said S Nat Commun. 2025; 16(1):1869.

PMID: 39984443 PMC: 11845630. DOI: 10.1038/s41467-025-56935-2.


Serum Level of Cadherin-P (CDH3) Is a Novel Predictor of Cardiovascular Events Related to Atherosclerosis in a 3-Year Follow-Up Study.

Gumanova N, Vasilyev D, Bogdanova N, Drapkina O J Clin Med. 2024; 13(21).

PMID: 39518432 PMC: 11546736. DOI: 10.3390/jcm13216293.


Ultrafast sequence-based prediction model and nomogram to differentiate additional suspicious lesions on preoperative breast MRI.

Kim H, Chi S, Kim K, Han B, Ko E, Choi J Eur Radiol. 2024; 35(1):188-201.

PMID: 39014088 DOI: 10.1007/s00330-024-10931-0.


Body mass index stratification optimizes polygenic prediction of type 2 diabetes in cross-biobank analyses.

Ojima T, Namba S, Suzuki K, Yamamoto K, Sonehara K, Narita A Nat Genet. 2024; 56(6):1100-1109.

PMID: 38862855 DOI: 10.1038/s41588-024-01782-y.


Using Machine Learning to Evaluate the Value of Genetic Liabilities in the Classification of Hypertension within the UK Biobank.

Maccarthy G, Pazoki R J Clin Med. 2024; 13(10).

PMID: 38792496 PMC: 11122671. DOI: 10.3390/jcm13102955.


References
1.
Siontis G, Tzoulaki I, Siontis K, Ioannidis J . Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ. 2012; 344:e3318. DOI: 10.1136/bmj.e3318. View

2.
Heng D, Xie W, Regan M, Harshman L, Bjarnason G, Vaishampayan U . External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol. 2013; 14(2):141-8. PMC: 4144042. DOI: 10.1016/S1470-2045(12)70559-4. View

3.
Kerr K, Wang Z, Janes H, McClelland R, Psaty B, Pepe M . Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology. 2013; 25(1):114-21. PMC: 3918180. DOI: 10.1097/EDE.0000000000000018. View

4.
Chia Y, Lim H, Ching S . Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study. BMC Cardiovasc Disord. 2014; 14:163. PMC: 4246627. DOI: 10.1186/1471-2261-14-163. View

5.
Pencina M, DAgostino R, Pencina K, Janssens A, Greenland P . Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012; 176(6):473-81. PMC: 3530349. DOI: 10.1093/aje/kws207. View